Hodgkin's Disease — Prognosis, Treatment and Etiologic and Immunologic Considerations

Abstract

TWO decades have passed since the publication of the classic Medical Progress series on Hodgkin's disease by Jackson and Parker.¹ In an overall assessment the disease remains, as it was in 1944, a fascinating but frustrating pathological and clinical entity of unknown etiology and usually fatal outcome. Nevertheless, despite such a negative summation, much has been learned in the last twenty years. Investigations of Hodgkin's disease itself and in the tumor-virus field in general place the ignorance of etiology in new perspective. A number of careful studies of prognosis allow the notoriously uncertain course of the disease to be predicted . . .